Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193125-26-138247
Filing Date
2026-04-01
Accepted
2026-04-01 17:24:39
Documents
2
Period of Report
2026-03-30

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1777
2 EX-24 ck0001800315-ex24.htm EX-24 11988
  Complete submission text file 0001193125-26-138247.txt   15429
Mailing Address C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105
Business Address
Jarrett Jennifer (Reporting) CIK: 0001671311 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39655 | Film No.: 26829542

Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 (781) 281-9020
Damora Therapeutics, Inc. (Issuer) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)